Literature DB >> 3961468

Intracoronary thrombolytic therapy performed within a coronary care unit: one year's experience.

W S Hillis, C R Jones, M Been, B C Campbell, W F Fulton.   

Abstract

Acute myocardial infarction is associated with a high incidence of occluding coronary arterial thrombi. Thrombolytic therapy has been advocated to restore coronary artery blood flow and to reduce myocardial damage. Coronary arteriography and intracoronary thrombolytic therapy was administered to 61 patients admitted to a Coronary Care Unit within eight hours of symptoms. Successful reperfusion was obtained in 38 of 46 single vessel occlusions associated with a first coronary attack. Failure of reperfusion occurred in patients with two vessel occlusions or with cardiogenic shock. This study demonstrates the feasibility of applying this technique within a Coronary Care Unit with low capital and running costs, and suggests that its widespread application is possible even within the setting of a District General Hospital.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3961468     DOI: 10.1177/003693308603100106

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  6 in total

1.  Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial.

Authors:  Peter J McCartney; Hany Eteiba; Annette M Maznyczka; Margaret McEntegart; John P Greenwood; Douglas F Muir; Saqib Chowdhary; Anthony H Gershlick; Clare Appleby; James M Cotton; Andrew Wragg; Nick Curzen; Keith G Oldroyd; Mitchell Lindsay; J Paul Rocchiccioli; Aadil Shaukat; Richard Good; Stuart Watkins; Keith Robertson; Christopher Malkin; Lynn Martin; Lynsey Gillespie; Thomas J Ford; Mark C Petrie; Peter W Macfarlane; R Campbell Tait; Paul Welsh; Naveed Sattar; Robin A Weir; Keith A Fox; Ian Ford; Alex McConnachie; Colin Berry
Journal:  JAMA       Date:  2019-01-01       Impact factor: 56.272

2.  Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.

Authors:  W S Hillis; R S Hornung; K J Hogg; N Hockings; J M Burns; F G Dunn
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker.

Authors:  K J Hogg; R S Hornung; C A Howie; N Hockings; F G Dunn; W S Hillis
Journal:  Br Heart J       Date:  1988-10

4.  Coronary arteriography in a district general hospital: feasibility, safety, and diagnostic accuracy.

Authors:  K Ranjadayalan; P G Mills; D C Sprigings; K Mourad; P Magee; A D Timmis
Journal:  BMJ       Date:  1990-03-24

5.  A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction.

Authors:  J D Gemmill; K J Hogg; P D MacIntyre; N Booth; A P Rae; F G Dunn; W S Hillis
Journal:  Br Heart J       Date:  1991-08

6.  Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time.

Authors:  Peter J McCartney; Annette M Maznyczka; Hany Eteiba; Margaret McEntegart; Keith G Oldroyd; John P Greenwood; Neil Maredia; Matthias Schmitt; Gerry P McCann; Timothy Fairbairn; Elisa McAlindon; Campbell Tait; Paul Welsh; Naveed Sattar; Vanessa Orchard; David Corcoran; Thomas J Ford; Aleksandra Radjenovic; Ian Ford; Alex McConnachie; Colin Berry
Journal:  J Am Coll Cardiol       Date:  2020-03-31       Impact factor: 24.094

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.